Krystal Biotech

Krystal Biotech

KRYS· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +57.4% in FY2025

Krish S. Krishnan is the CEO of Krystal Biotech and was paid $10.4M in FY2025 (Dec), down 33%.

Pay$100 in the stock at the end of FY20 → $262
CEO pay is from each Krystal Biotech proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Krish S. KrishnanFY2025
  2. 2Suma M. KrishnanFY2025
  3. 3Kathryn A. RomanoFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Krystal Biotech paid its 3 named executives $19.6M in total in FY2025 (Dec). CEO Krish S. Krishnan was paid $10.4M of that.

Name
Krish S. KrishnanChair and Chief Executive Officer
Suma M. KrishnanPresident, R&DNot disclosed
Kathryn A. RomanoChief Accounting OfficerNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers19

See all

The FY2024 (Dec) proxy of Krystal Biotech names 19 peer companies for pay. Among Krystal Biotech and these peers, CEO pay was 2nd highest of 9 and total shareholder return was 2nd highest of 9.

2nd highest of 9in Krystal Biotech and its pay peers, FY2024 (Dec) by CEO pay:

$6.8M$18.8M

2nd highest of 9in Krystal Biotech and its pay peers, FY2024 (Dec) by total shareholder return:

$43$289

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board2

See all
  • Daniel S. JanneyLead independent director · 8 yr on the boardIndependentAudit, Compensation (Chair), Nominating and Corporate Governance—Paid as an executive
  • E. Rand SutherlandDirector · 2 yr on the boardIndependentAudit—Paid as an executive

The board of the latest proxy (FY2024).

Activity

Filings6

See all
Proxy statementDEF 14AApr 3, 2026FY2025
Annual report10-KFeb 17, 2026FY2025
Proxy statementDEF 14AApr 3, 2025FY2024
Annual report10-KFeb 19, 2025FY2024
Proxy statementDEF 14AApr 4, 2024FY2023
Annual report10-KFeb 26, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data